weight loss

Vivus Hammered After FDA Panel's 'No' Vote

Pharmaceutical company Vivus is getting hammered in premarket trading, sinking more than 50% to around $5.32 in the wake of Thursday's vote by an FDA advisory panel against approving its weight-loss drug, Qnexa, based on safety concerns.

FDA Panel Rejects Weight-Loss Drug Qnexa

Pharmaceutical company Vivus and investors waited anxiously Thursday for the vote of an FDA advisory panel on the weight-loss drug Qnexa. The verdict is in, and by a vote of 9 to 7, panelists didn't support approving the drug as an obesity treatment.

Weight-Loss-Drug Maker Vivus Soars on FDA Review

An expert panel will review Vivus' potential blockbuster drug Qnexa on Thursday, with the FDA making a decision in October. The FDA acknowledges the drug's effectiveness in cutting weight, but it will certainly draw scrutiny over its side effects.

The Money Diet: a setback in week 6

I'm afraid to look at my bathroom scale. I have no idea if I've lost or gained weight this week. Well, actually, I have an idea, which is why I'd...

Lose weight without breaking the bank

There is an interesting story about weight loss in the latest edition of USA Today. The article profiles people who have lost a significant amount of...